Setmelanotide Acetate: A Comprehensive Guide to its Properties, Applications, and Research Significance
Unlocking the potential of MC4R agonism for genetic obesity research and therapeutic development.
Get a Quote & SampleProduct Core Value
Setmelanotide Acetate
Setmelanotide Acetate, identified by CAS number 1294000-61-5, is a highly pure research reagent essential for scientific investigation into the MC4R pathway. As a peptide-based agonist, it plays a critical role in understanding and developing treatments for genetic obesity.
- Leveraging Setmelanotide Acetate research reagent for advancements in understanding MC4R pathway interactions and their impact on metabolic regulation.
- Exploring the potential of MC4R agonist for obesity treatment, particularly for rare genetic conditions like Bardet-Biedl syndrome.
- Investigating Setmelanotide Acetate CAS 1294000-61-5 in preclinical studies to validate its efficacy in models of genetic obesity.
- Utilizing peptide-based obesity drug research to identify novel therapeutic strategies for hyperphagia and weight management.
Key Advantages
Precision Targeting of MC4R Pathway
This compound allows for precise modulation of the MC4R pathway, a crucial target for addressing the root causes of genetic obesity.
High Purity for Reliable Research
With a purity of >=99%, Setmelanotide Acetate ensures reliable and reproducible results in scientific research, crucial for validating new POMC deficiency obesity therapies.
Supports Development of Novel Therapies
Its application as a research reagent aids in the development of innovative peptide-based pharmaceuticals for conditions like LEPR deficiency obesity treatment.
Key Applications
Genetic Obesity Research
Serves as a vital tool in understanding the pathophysiology of genetic obesity, supporting research into PCSK1 deficiency obesity treatment.
Pharmacological Studies
Enables detailed pharmacological studies of MC4R agonists, contributing to the development of new weight management strategies.
Preclinical Drug Development
Used in preclinical settings to evaluate the efficacy and safety of potential new drugs for rare obesity disorders.
Biotechnology Innovation
Facilitates advancements in biotechnology by providing a key compound for peptide synthesis and modification research.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).